Anthony McCanta, MD
Adult Congenital Heart Disease · Portland, ORNPI 1730277658
Payments from drug & device makers
Across 128 payments — averaging $265.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- Medical Device Business Services, Inc.$11K
- Altathera Pharmaceuticals LLC$3K
- Abbott$2K
- Biosense Webster, Inc.$1K
- Boston Scientific$398
- plus $464 from 9 others
What the payments were for
- Consulting fees$14,17542%
- Speaking & faculty fees$11,32533%
- Travel & lodging$4,22312%
- Food & beverage$4,12512%
- Education$820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 42 | $15,496 |
| Medical Device Business Services, Inc. | 6 | $11,025 |
| Altathera Pharmaceuticals LLC | 2 | $3,455 |
| Abbott | 12 | $1,624 |
| Biosense Webster, Inc. | 37 | $1,468 |
| Boston Scientific | 14 | $398 |
| Irhythm Technologies, Inc. | 1 | $81 |
| Cardiva Medical, Inc. | 2 | $76 |
| Tolmar, Inc. | 3 | $60 |
| Neurocrine Biosciences, Inc. | 2 | $57 |
| Kyowa Kirin, Inc. | 2 | $50 |
| Philips North America LLC | 1 | $49 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$11,574
- Micra$5,799
- Sotalol Hydrochloride$3,455
- AVEIR$1,128
- EVERA MRI XT DR SURESCAN$1,084
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$169
- GENERAL - THERAPIES$133
How this compares
Too few adult congenital heart disease providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Chloride0.9 % Sodium Chloride | 12 | $661 |
| Furosemide | 15 | $92 |
| Metoprolol Succinate | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Other adult congenital heart disease in Portland
- Craig BrobergPortland$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.